Hengge Xie

1.3k total citations · 1 hit paper
29 papers, 687 citations indexed

About

Hengge Xie is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Hengge Xie has authored 29 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Hengge Xie's work include Dementia and Cognitive Impairment Research (14 papers), Alzheimer's disease research and treatments (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Hengge Xie is often cited by papers focused on Dementia and Cognitive Impairment Research (14 papers), Alzheimer's disease research and treatments (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Hengge Xie collaborates with scholars based in China, Australia and Canada. Hengge Xie's co-authors include Huali Wang, Xin Yu, Yongan Sun, Serge Gauthier, Wendy Weidner, Yanqing Tang, Paola Barbarino, Henry Brodaty, José Luís Molinuevo and Enyan Yu and has published in prestigious journals such as The Lancet, Scientific Reports and Journal of the American Geriatrics Society.

In The Last Decade

Hengge Xie

25 papers receiving 670 citations

Hit Papers

Dementia care during COVID-19 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengge Xie China 9 222 221 185 144 87 29 687
Enyan Yu China 9 189 0.9× 233 1.1× 169 0.9× 145 1.0× 69 0.8× 21 623
Claudia A. Orengo United States 17 373 1.7× 203 0.9× 307 1.7× 74 0.5× 117 1.3× 41 1.1k
Annabel Price United Kingdom 18 300 1.4× 190 0.9× 164 0.9× 81 0.6× 79 0.9× 41 1.1k
John Brockington United States 14 478 2.2× 181 0.8× 211 1.1× 42 0.3× 128 1.5× 15 917
Elena Tsoy United States 15 316 1.4× 50 0.2× 198 1.1× 44 0.3× 101 1.2× 36 661
Naruhiko Maki Japan 13 489 2.2× 91 0.4× 176 1.0× 154 1.1× 196 2.3× 24 770
Rita Prieto Spain 13 124 0.6× 279 1.3× 95 0.5× 58 0.4× 74 0.9× 34 749
J Fellows United Kingdom 8 317 1.4× 99 0.4× 187 1.0× 23 0.2× 96 1.1× 17 553
Geraint Price United Kingdom 10 84 0.4× 212 1.0× 92 0.5× 48 0.3× 57 0.7× 18 619
David Lira Peru 15 386 1.7× 45 0.2× 91 0.5× 79 0.5× 86 1.0× 47 601

Countries citing papers authored by Hengge Xie

Since Specialization
Citations

This map shows the geographic impact of Hengge Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengge Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengge Xie more than expected).

Fields of papers citing papers by Hengge Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengge Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengge Xie. The network helps show where Hengge Xie may publish in the future.

Co-authorship network of co-authors of Hengge Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Hengge Xie. A scholar is included among the top collaborators of Hengge Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengge Xie. Hengge Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jing, Jiao Fan, Lian Li, et al.. (2025). Blockage of CCL3 with neutralizing antibody reduces neuroinflammation and reverses Alzheimer disease phenotypes. Brain Behavior and Immunity. 128. 400–415.
3.
Cong, Bin, Hengge Xie, Jingnian Ni, et al.. (2025). Perspective on strengthening dementia prevention and control system: a comprehensive framework for national health. Frontiers of Medicine. 19(5). 865–870. 1 indexed citations
4.
Shang, Yanchang, Shuhui Wang, Chao Wei, et al.. (2024). Association of chronic kidney disease with cognitive impairment risk in middle-aged and older adults: the first longitudinal evidence from CHARLS. Scientific Reports. 14(1). 23265–23265. 4 indexed citations
5.
Qiu, Shuxian, Mei Zhao, Haifeng Zhang, et al.. (2024). Heterogeneity in the level of dementia literacy among community doctors in China: A latent profile analysis. Journal of Global Health. 14. 4161–4161. 3 indexed citations
6.
Shang, Yanchang, et al.. (2023). Effect of blood pressure on mortality in patients with cognitive impairment: a prospective cohort study. Frontiers in Cardiovascular Medicine. 10. 1282131–1282131.
7.
Wang, Chen, Bo Wu, Tong Chen, et al.. (2022). A New Early Warning Method for Human-Computer Interaction of Alzheimer's Disease Patients Based on Deep Learning. Traitement du signal. 39(5). 1655–1662. 4 indexed citations
8.
Fu, Liping, Jinming Zhang, Kaixiang Zhou, et al.. (2022). In vivo imaging of tau deposition in Alzheimer’s disease using both [18F]-THK5317 and [18F]-S16: A pilot human study. Frontiers in Aging Neuroscience. 14. 994750–994750. 3 indexed citations
9.
Li, Bei, Dejun Liu, Qiaoqin Wan, et al.. (2022). Differences in treatment for Alzheimer's disease between urban and rural areas in China. Frontiers in Neurology. 13. 996093–996093. 6 indexed citations
10.
Wei, Mingqing, Jing Shi, Ting Li, et al.. (2022). Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease. BMC Geriatrics. 22(1). 471–471.
11.
Li, Yuxian, Fangda Leng, Qi Xiong, et al.. (2022). Factors Associated With Alzheimer’s Disease Patients’ Caregiving Status and Family Caregiving Burden in China. Frontiers in Aging Neuroscience. 14. 865933–865933. 10 indexed citations
12.
Ni, Jingnian, Yuou Teng, Mingwan Su, et al.. (2022). Effect of hearing aids on cognitive functions in middle-aged and older adults with hearing loss: A systematic review and meta-analysis. Frontiers in Aging Neuroscience. 14. 1017882–1017882. 12 indexed citations
13.
Fu, Liping, Zhi Zhou, Jinming Zhang, et al.. (2021). Functional Abnormality Associated With Tau Deposition in Alzheimer’s Disease – A Hybrid Positron Emission Tomography/MRI Study. Frontiers in Aging Neuroscience. 13. 758053–758053. 5 indexed citations
14.
Bai, Anying, Weihao Xu, Jing Sun, et al.. (2021). Associations of sarcopenia and its defining components with cognitive function in community-dwelling oldest old. BMC Geriatrics. 21(1). 292–292. 44 indexed citations
15.
Wang, Huali, Tao Li, Paola Barbarino, et al.. (2020). Dementia care during COVID-19. The Lancet. 395(10231). 1190–1191. 381 indexed citations breakdown →
16.
Wang, Huali, Hengge Xie, Qiumin Qu, et al.. (2019). The continuum of care for dementia: needs, resources and practice in China. Journal of Global Health. 9(2). 20321–20321. 34 indexed citations
17.
He, Yao, Fuxin Luan, Yao Yao, et al.. (2017). [China Hainan Centenarian Cohort Study: study design and preliminary results].. PubMed. 38(9). 1292–1298. 4 indexed citations
18.
Lv, Xiaozhen, et al.. (2015). Development and validation of the geriatric depression inventory in Chinese culture. International Psychogeriatrics. 27(9). 1505–1511. 20 indexed citations
19.
Shi, Jing, Xiawei Liu, Mingqing Wei, et al.. (2013). The Pattern Element Scale: A Brief Tool of Traditional Medical Subtyping for Dementia. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 5 indexed citations
20.
Xie, Hengge, Xi Zhang, Zhenfu Wang, et al.. (2010). [A cross-sectional study of neurological disease in the veterans of military communities in Beijing].. PubMed. 49(6). 463–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026